Futura Medical (FUM) - Cash Flow Conversion Efficiency

Latest as of December 2024: 0.384x

Based on the latest financial reports, Futura Medical (FUM) has a cash flow conversion efficiency ratio of 0.384x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX3.44 Million ≈ $418.82 USD) by net assets (GBX8.96 Million ≈ $1.09K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Futura Medical - Cash Flow Conversion Efficiency Trend (2001–2024)

This chart illustrates how Futura Medical's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read FUM total liabilities for a breakdown of total debt and financial obligations.

Futura Medical Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Futura Medical ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Sonder Holdings Inc NASDAQ:SOND	0.040x
Premier African Minerals Ltd LSE:PREM	-0.001x
Unicorn Mineral Resources PLC LSE:UMR	N/A
Anemoi International Ltd LSE:AMOI	-0.089x
Physiomics Plc LSE:PYC	-0.514x
Gaming Technologies Inc. Common Stock NASDAQ:GMGT	0.110x
FAT Brands Inc NASDAQ:FATBW	0.050x
BSF Enterprise Plc LSE:BSFA	-0.102x

Annual Cash Flow Conversion Efficiency for Futura Medical (2001–2024)

The table below shows the annual cash flow conversion efficiency of Futura Medical from 2001 to 2024. For the full company profile with market capitalisation and key ratios, see Futura Medical (FUM) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	GBX8.96 Million ≈ $1.09K	GBX438.41K ≈ $53.34	0.049x	-53.02%
2023-12-31	GBX5.48 Million ≈ $666.37	GBX570.25K ≈ $69.38	0.104x	+108.51%
2022-12-31	GBX4.72 Million ≈ $574.23	GBX-5.78 Million ≈ $-702.69	-1.224x	-207.24%
2021-12-31	GBX9.72 Million ≈ $1.18K	GBX-3.87 Million ≈ $-471.26	-0.398x	+92.52%
2020-12-31	GBX853.54K ≈ $103.85	GBX-4.54 Million ≈ $-552.79	-5.323x	+95.71%
2019-12-31	GBX53.65K ≈ $6.53	GBX-6.66 Million ≈ $-809.87	-124.063x	-23226.94%
2018-12-31	GBX8.85 Million ≈ $1.08K	GBX-4.71 Million ≈ $-572.83	-0.532x	-16.00%
2017-12-31	GBX9.11 Million ≈ $1.11K	GBX-4.17 Million ≈ $-507.95	-0.458x	-74.94%
2016-12-31	GBX12.58 Million ≈ $1.53K	GBX-3.30 Million ≈ $-401.27	-0.262x	+76.61%
2015-12-31	GBX4.79 Million ≈ $582.35	GBX-5.36 Million ≈ $-652.63	-1.121x	-255.27%
2014-12-31	GBX9.72 Million ≈ $1.18K	GBX-3.07 Million ≈ $-373.13	-0.315x	+84.53%
2013-12-31	GBX987.77K ≈ $120.18	GBX-2.01 Million ≈ $-245.04	-2.039x	-201.85%
2012-12-31	GBX2.87 Million ≈ $349.59	GBX-1.94 Million ≈ $-236.14	-0.675x	-1.47%
2011-12-31	GBX2.76 Million ≈ $335.57	GBX-1.84 Million ≈ $-223.39	-0.666x	+42.71%
2010-12-31	GBX901.00K ≈ $109.63	GBX-1.05 Million ≈ $-127.39	-1.162x	-63.37%
2009-12-31	GBX1.85 Million ≈ $225.46	GBX-1.32 Million ≈ $-160.36	-0.711x	+68.03%
2008-12-31	GBX886.00K ≈ $107.80	GBX-1.97 Million ≈ $-239.81	-2.225x	-170.33%
2007-12-31	GBX2.77 Million ≈ $337.39	GBX-2.28 Million ≈ $-277.65	-0.823x	-75.43%
2006-12-31	GBX3.95 Million ≈ $480.36	GBX-1.85 Million ≈ $-225.33	-0.469x	+56.29%
2005-12-31	GBX1.98 Million ≈ $240.91	GBX-2.12 Million ≈ $-258.55	-1.073x	-177.22%
2004-12-31	GBX3.75 Million ≈ $456.02	GBX-1.45 Million ≈ $-176.54	-0.387x	+31.27%
2003-12-31	GBX2.41 Million ≈ $293.11	GBX-1.36 Million ≈ $-165.11	-0.563x	+19.43%
2003-01-31	GBX1.52 Million ≈ $184.82	GBX-1.06 Million ≈ $-129.21	-0.699x	-8.85%
2002-01-31	GBX2.00 Million ≈ $243.22	GBX-1.28 Million ≈ $-156.23	-0.642x	-159.76%
2001-01-31	GBX-294.00K ≈ $-35.77	GBX-316.00K ≈ $-38.45	1.075x	--

About Futura Medical

LSE:FUM UK Biotechnology

Market Cap

$27.79K

GBX228.37 Million GBX

Market Cap Rank

#31192 Global

#1244 in UK

Share Price

GBX0.75

Change (1 day)

-10.77%

52-Week Range

GBX0.75 - GBX13.43

All Time High

GBX84.52